Rethinking aid-in-dying medications
Doctors in the Northwest are once again rethinking aid-in-dying medications because they’re taking too long to work.
Doctors in the Northwest are once again rethinking aid-in-dying medications because they’re taking too long to work.
“This is really an amazing opportunity to be part of establishing policy and initiating something in medicine. This is a major change … [that] very, very few people know anything about and how to do it.”
Elizabeth Wallner, diagnosed with Stage 4 colon cancer five years ago, has one word to describe the pharmaceutical executive who decided to double the price of Seconal: “Scumbag.”
The pending dismissal is a setback for aid-in-dying advocates, who argue that physicians should be able to prescribe life-ending medications for terminally ill patients who request them to avoid unnecessary suffering.